AOL Money & Finance

BEC posts

Feed

Analyst upgrades, downgrades and initiations: AA, NOK, EXPE, MTB, CSC ...

Analyst upgrades:
  • JP Morgan upgraded Alcoa (NYSE: AA) to Overweight from Neutral and added shares to its Focus List. The analyst said the equity offering and dividend cut provide enough "liquidity insurance" to make it through 2009 and now views risk/reward as attractive.
  • Deutsche Bank upgraded Asbury Automotive (NYSE: ABG) to Buy from Hold as it finds the current valuation attractive and thinks the company's cost savings will drive upside in a recovery. The firm raised its target price to $7 from $5.50.
  • Barclays upgraded Beckman Coulter (NYSE: BEC) to Overweight from Equal Weight. Following their healthcare conference and management meetings, the firm sees increased visibility into revenues.
  • Waddell & Reed (NYSE: WDR) was raised to Buy from Neutral at Goldman.
  • Nokia (NYSE: NOK) was upgraded to Outperform from Neutral at Credit Suisse.
  • Brocade (NASDAQ: BRCD) was lifted to Outperform from Sector Perform at RBC Capital.

Continue reading Analyst upgrades, downgrades and initiations: AA, NOK, EXPE, MTB, CSC ...

Analyst initiations: BEC, BT and MITI

MOST NOTEWORTHY: Beckman Coulter, BT Group and Micromet were today's noteworthy initiations:
  • Oppenheimer believes Beckman Coulter (NYSE:BEC) is well-positioned to leverage its broad installed base in the clinical lab market to increase sales of its consumable and a new molecular diagnostics instrument expected in 2010. The firm initiated shares with an Outperform rating and $80 target.
  • Societe Generale expects BT Group's (NYSE:BT) domestic revenues to deteriorate as line erosion accelerates; shares were assumed with a Sell rating.
  • Roth Capital started Micromet (NASDAQ:MITI) with a Buy rating and $3 target. The firm expects the company's proprietary 'BiTE' antibody platform to gain validation as its lead candidate MT103 starts accumulating clinical data in multiple hematology indications.
OTHER INITIATIONS:
  • Yahoo! (NASDAQ:YHOO) was initiated with a Neutral rating at Merrill.
  • Piper resumed coverage of Alexion Pharma (NASDAQ:ALXN) with a Buy rating and $88 target.
  • MedAssets (NASDAQ:MDAS) was started at Jefferies with a Buy rating and $25 target.

Analyst downgrades: GPCB, AKAM, Q, SFLY and LDK

MOST NOTEWORTHY: GPC Biotech, Akamai, Qwest, Shutterfly and LDK Solar were today's noteworthy downgrades:
  • GPC Biotech (NASDAQ: GPCB) was downgraded to Sell from Neutral at Goldman, to Sell from Hold at Deutsche Bank and to Underweight from Overweight at Lehman after the company's phase III trial of satraplatin to treat prostate cancer did not meet its primary endpoint.
  • Deutsche Bank downgraded shares of Akamai Technologies (NASDAQ: AKAM) to Hold from Buy on valuation following the recent rally as they believe concerns around slowing growth, margins and capital efficiency will limit upside.
  • Qwest Communications (NYSE: Q) was downgraded to Sector Performer from Outperformer at CIBC and to Neutral from Overweight at JP Morgan following the company's disappointing Q3 results.
  • Jefferies downgraded shares of Shutterfly (NASDAQ: SFLY) following the better-than-expected Q3 results due to valuation.
  • Piper downgraded shares of LDK Solar (NYSE: LDK) to Market Perform from Outperform, as they expect higher blended poly cost for the company due to tightening scrap poly supply and increased competition.
OTHER DOWNGRADES:

Before the bell 3-26-07: Looking to continue positive momentum

Stock futures are positive in early morning trading indicating a possible similar open for stocks to start the week following a week of solid gains that saw the Dow return to positive territory for the year.

Today investors await some housing data. Still jittery about the subprime mortgage market, investors keep a close eye on the housing market as a whole. Higher oil prices as tensions with Iran increase are affecting pre-market indications as well.

At 10:00 a.m. this morning, February new home sales will be released. The market expects a rise from 937,000 in January to 995,000 in February.

Overseas, Asian markets closed mostly higher. Stocks in Europe are mixed. The dollar continued to strengthen against the euro and the yen.

In corporate news:

Citigroup Inc. (NYSE:C) is putting forth a restructuring plan that could involve cutting some 15,000 job and a charge against earnings of more than $1 billion, according to the Wall Street Journal.

Intel Corp. (NASDAQ:INTC) said it will build a $2.5 billion chip factory in northeastern China to better tap into the booming Chinese market.

Beckman Coulter, Inc. (NYSE:BEC) announced it is acquiring the biomedical research company Biosite, Inc. for approximately $1.55 billion.

German sports car maker Porsche has increased its stake in Volkswagen to 30.9% by exercising an option to take an extra 3.6% voting stake as of Wednesday. Under German law this constitutes a takeover and would require Porsche to make an offer to other VW shareholders.

Notable analyst calls this morning:
  • Time Warner Inc. (NYSE:TWX) is up 0.8% in early pre-market trading after Bear Stearns upgraded it from Peer Perform to Outperform.
  • Dell Inc. (NASDAQ:DELL) was upgraded from Neutral to Buy at Goldman Sachs. DELL shares are up nearly 3% in pre-market.
  • United Technologies Corp. (NYSE:UTX) was upgraded to Outperform from Neutral by Credit Suisse on hopes for the company's quality control program.

Symbol Lookup
IndexesChangePrice
DJIA+30.6910,464.40
NASDAQ+6.872,176.05
S&P 500+4.981,110.63

Last updated: November 27, 2009: 08:18 AM

BloggingStocks Exclusives

Hot Stocks

DailyFinance Headlines

Latest from BloggingBuyouts

WalletPop Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance